SARS-CoV-2 Vaccine in Dialysis Patients: Time for a Boost?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SARS-CoV-2 Vaccine in Dialysis Patients: Time for a Boost?

Published:2022-02 Issue:2 Volume:79 Page:162-163
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Krueger Karen M.,Halasa Natasha,Ison Michael G.^ORCID

Publisher

Elsevier BV

Subject

Nephrology

Reference13 articles.

1. Excess death estimates in patients with end-stage renal disease - United States, February-August 2020;Ziemba;Am J Transplant,2021

2. Practical guide to vaccination in all stages of CKD, including patients treated by dialysis or kidney transplantation;Krueger;Am J Kidney Dis,2020

3. Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy;Ikizler;Kidney Int,2021

4. SARS-CoV-2 antibody response after a third dose of the BNT162b2 vaccine in patients receiving maintenance hemodialysis or peritoneal dialysis;Bensouna;Am J Kidney Dis,2022

5. Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19;Doria-Rose;N Engl J Med,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney disease;Nature Communications;2023-09-27

2. Omicron variant BA.1, BA.5, BQ.1.1, and XBB.1.5 Neutralizing Antibodies Following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 Bivalent Vaccination;2023-05-05

3. Humoral and cellular response after BNT162b2 vaccine booster in hemodialysis patients and kidney transplant recipients;Clinical and Experimental Nephrology;2023-02-16

4. Vaccination against SARS-CoV-2 in Haemodialysis Patients: Spike’s Ab Response and the Influence of BMI and Age;International Journal of Environmental Research and Public Health;2022-08-15

5. BNT162b2 Booster Vaccination Induced Immunity against SARS-CoV-2 Variants among Hemodialysis Patients;Vaccines;2022-06-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3